CORC

在结果中检索

CORC

浏览/检索结果: 共82条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells 期刊论文
THORACIC CANCER, 2021, 页码: 9
作者:  Zhang, Mi;  Quan, Haitian;  Fu, Li;  Li, Yun;  Fu, Haoyu
收藏  |  浏览/下载：21/0  |  提交时间：2021/05/24
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文
MOLECULAR CANCER, 2020, 卷号: 19, 期号: 1, 页码: 15
作者:  Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang
收藏  |  浏览/下载：44/0  |  提交时间：2020/07/01
Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFR(L858R/T790M/C797S) 期刊论文
ACS MEDICINAL CHEMISTRY LETTERS, 2019, 卷号: 10, 期号: 6, 页码: 869-873
作者:  Li, Qiannan;  Zhang, Tao;  Li, Shiliang;  Tong, Linjiang;  Li, Junyu
收藏  |  浏览/下载：23/0  |  提交时间：2020/07/01
EGFR  mutant  inhibitor  C797S  
The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104) 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 3
作者:  Xu, Song-Tao;  Xi, Jun-Jie;  Zhong, Wen-Zhao;  Mao, Wei-Min;  Wu, Lin
收藏  |  浏览/下载：38/0  |  提交时间：2019/12/05
Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis 期刊论文
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 卷号: 34, 期号: 2
作者:  Huang, Ruofan;  Ge, Mengxi;  Zhou, Xinli;  Ji, Xiaoyu;  Liao, Li
收藏  |  浏览/下载：23/0  |  提交时间：2019/12/05
Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients 期刊论文
DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 卷号: 13
作者:  Zhang, Tengfei;  Zhang, Lu;  Xie, Yuancai;  Li, Bing;  Ma, Yafeng
收藏  |  浏览/下载：27/0  |  提交时间：2019/12/05
Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients 期刊论文
Drug Design, Development and Therapy, 2019, 卷号: 13, 页码: 1809-1817
作者:  Liu, Jixian;  Mu, Zhimin;  Liu, Li;  Li, Kang;  Jiang, Richeng
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/03
A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation 期刊论文
Journal of Experimental & Clinical Cancer Research, 2019, 卷号: Vol.38 No.1
作者:  Meifang Li;  Jilong Yang;  Lenghe Zhang;  Sanfang Tu;  Xuan Zhou
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/13
A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation. 期刊论文
Journal of Experimental & Clinical Cancer Research, 2019, 卷号: Vol.38 No.1
作者:  Li, Meifang;  Yang, Jilong;  Zhang, Lenghe;  Tu, Sanfang;  Zhou, Xuan
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/13
Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study 期刊论文
ONCOTARGETS AND THERAPY, 2019, 卷号: 12, 页码: 8311-8318
作者:  An, Ning;  Wang, Haoyi;  Li, Ji;  Zhai, Xiaoyang;  Jing, Wang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/11

©版权所有 ©2017 CSpace - Powered by CSpace